Neoplastic meningitis epidemiology and demographics
|
Neoplastic meningitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Neoplastic meningitis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Neoplastic meningitis epidemiology and demographics |
|
Neoplastic meningitis epidemiology and demographics in the news |
|
Blogs on Neoplastic meningitis epidemiology and demographics |
|
Risk calculators and risk factors for Neoplastic meningitis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Neoplastic meningitis occurs in approximately 3000-5000 of 100,000 patients with solid tumors, 5000-15,000 of 100,000 patients with leukemia, and 1000-2000 of 100,000 patients with primary brain tumors.[1][2]
Epidemiology and Demographics
Incidence
- Neoplastic meningitis occurs in approximately 3000-5000 of 100,000 patients with solid tumors.
- Neoplastic meningitis occurs in approximately 5000-15,000 of 100,000 patients with leukemia.
- Neoplastic meningitis occurs in approximately 1000-2000 of 100,000 patients with primary brain tumors.[1][2]
Prevalence
- Observational studies show that neoplastic meningitis develop in 1-5% of solid tumors, of which adenocarcinoma is the most frequently observed histology.
- Neoplastic meningitis typically develop in the setting of an advanced stage and widely disseminated cancer in 70% of the cases. It can also present during the patients disease-free interval or remission in 20% of the time, and even be the first manifestation of cancer (5-10%) occasionally.[3]
Age
- Neoplastic meningitis occurs more in elderly people, as it is associated with other primary cancer development.
References
- ↑ 1.0 1.1 Gleissner, Beate; Chamberlain, Marc Charles (2006). "Neoplastic meningitis". The Lancet Neurology. 5 (5): 443–452. doi:10.1016/S1474-4422(06)70443-4. ISSN 1474-4422.
- ↑ 2.0 2.1 Hayat, M. A. Brain metastases from primary tumors : epidemiology, biology, and therapy. London: Elsevier/Academic Press, 2014. Print.| url=https://books.google.com/books?id=IloXAwAAQBAJ&pg=PA43&lpg=PA43&dq=leptomeningeal+carcinomatosis+is+present+in+1-5%25+of+patients+with+solid+tumors,+5-15%25+of+patients+with+leukemia,+and+1-2%25+of+patients+with+primary+brain+tumors.&source=bl&ots=ehEaDBCT5f&sig=vvSxdxDjNMBe0CdCP6fEcMaYJqU&hl=en&sa=X&ved=0ahUKEwi2ueuw37bKAhUG8j4KHWUUCoIQ6AEILTAC#v=onepage&q=leptomeningeal%20carcinomatosis%20is%20present%20in%201-5%25%20of%20patients%20with%20solid%20tumors%2C%205-15%25%20of%20patients%20with%20leukemia%2C%20and%201-2%25%20of%20patients%20with%20primary%20brain%20tumors.&f=false. Accessed on January 19, 2016
- ↑ "Neoplastic Meningitis".